Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

3.01.2.2 Each co-licensee will have rights and restrictions related to the Licensed Screening Patent Rights consistent with the terms of this Agreement, including all Sections of 3.01.2.1, 4.01, 4.01.1-4.01.3.
3.01.3 An assignment of all of OHSU’s claim of right, title, and interest to the Therapeutic Patent (including the regular utility application) by OHSU to LICENSEE.
3.02   This Agreement confers no license or rights by implication, estoppel, or otherwise under any patent applications or patents of OHSU other than the Patent Rights regardless of whether such patents are dominant or subordinate to the patent rights granted.
 
3.03   OHSU retains the right to use the Patent Rights for educational and research purposes, and permit other academic and nonprofit organizations to use the Licensed Mouse Patent Rights and Licensed Screening Patent Rights for educational and non-commercial research purposes. In addition, for the Licensed Mouse Patent Rights, and Licensed Screening Patent Rights, a license is reserved on behalf of the Government, subject to Section 5.01 below.
 
3.04   LICENSEE agrees with the following:
3.04.1 LICENSEE shall not initiate breeding activities with MICE, other than between the pair(s) provided and direct descendants thereof, without advance written permission of OHSU.
3.04.2 LICENSEE shall use MICE only for animal (non-food) experimentation, and shall handle MICE humanely and in compliance with all applicable laws and regulations, including animal welfare regulations.
3.04.3 LICENSEE shall not transfer MICE to any other party, and will limit access to MICE to its researchers who are bound by the obligations of this Agreement.
3.04.4 LICENSEE assumes all responsibility for the safe use and handling of MICE, and will defend, indemnify and hold harmless OHSU, and its Directors, Trustees, employees, officers, fellows, students and agents against any and all claims of LICENSEE and third parties arising from its acceptance, use, storage, handling, or disposal of MICE.
3.04.5 This Agreement is a bailment of MICE from OHSU to LICENSEE, and ownership of MICE is not transferred to LICENSEE.
4.   SUBLICENSING
 
4.01   Upon written approval by OHSU, which approval will not be unreasonably withheld, LICENSEE may enter into sublicensing agreements for the Licensed Screening Patent Rights for the sole purpose of collaborating with the sublicensee in the discovery and